Details for 2018803112
Up to date per 04.04.2026
Actions
Details for 2018803112
Deleted
European Patent
25.03.2020 A
20.09.2023 B1
17.05.2017
US
201762507682 P
C07D 487/10 20060101AFI20210202BHEP
Owner
Denali Therapeutics Inc.161 Oyster Point Boulevard South San Francisco, California 94080US
Representative
No representatives present
Inventor
BONANOMI, Giorgioc/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco, California 94080US
ESTRADA, Anthony A.c/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco, California 94080US
FENG, Jianwen A.c/o Denali Therapeutics Inc. 161 Oyster Poin2nd Floor South San Francisco, California 94080US
FOX, Brianc/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco, California 94080US
FRANCINI, Cinzia Mariac/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco, California 94080US
HU, Chengc/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco, California 94080US
LESLIE, Colin Philipc/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco, California 94080US
OSIPOV, Maksimc/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco, California 94080US
SUDHAKAR, Ananthac/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco, California 94080US
SWEENEY, Zachary K.c/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco, California 94080US
DE VICENTE FIDALGO, Javierc/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco, California 94080US